Method of manufacture of 1,3-oxathiolane nucleosides

Details for Australian Patent Application No. 2004202930 (hide)

International Classifications

Event Publications

15 July 2004 Complete Application Filed

29 July 2004 Application Open to Public Inspection

Published as AU-B-2004202930

24 April 2008 Assignment before Grant

Triangle Pharmaceuticals, Inc.; Emory University The application has been assigned to Emory University; Gilead Sciences, Inc.

8 May 2008 Application Accepted

Published as AU-B-2004202930

3 July 2008 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 12 Jun 2008. Address for service in Australia - Davies Collison Cave Level 15 1 Nicholson Street Melbourne VIC 3000

4 September 2008 Standard Patent Sealed

13 November 2008 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 12 Jun 2008

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.